HIV type 1 glycoprotein 120 inhibits cardiac myocyte contraction

Fuhua Chen, Kevin Shannon, Shulan Ding, Monica E. Silva, Glenn T. Wetzel, Thomas S. Klitzner, Paul Krogstad

Research output: Contribution to journalArticlepeer-review


Cardiomyopathy is a common, life-threatening, but poorly understood complication of HIV infection. The purpose of the present study is to study the effects of an HIV surface envelope protein, glycoprotein 120 (gp120), on cell contraction and L-type Ca2+ current in rabbit ventricular myocytes. Rabbit ventricular cells were isolated by an enzyme dissociation method. Cell contractions were induced by electric field stimulation. Whole cell L-type Ca2+ channel currents were measured by the whole cell voltage-clamp technique. We found that perfusion with solution containing gp120 (0.1 μg/ml) derived from HIV-1SF2 significantly inhibited field- stimulated contractions and L-type Ca2+ current in rabbit ventricular myocytes as compared with perfusion with buffer alone. These results suggest that HIV-1 gp120 may directly contribute to cardiac dysfunction as seen in many HIV patients.

Original languageEnglish (US)
Pages (from-to)777-784
Number of pages8
JournalAIDS research and human retroviruses
Issue number11
StatePublished - 2002
Externally publishedYes

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases


Dive into the research topics of 'HIV type 1 glycoprotein 120 inhibits cardiac myocyte contraction'. Together they form a unique fingerprint.

Cite this